secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stimcell Energetics Inc. (STME)
CIK:        0001493712
Form:       8-K
Filed at:   2024-04-04T23:59:59+00:00
Accession:  0001393905-24-000114
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cell MedX elects four directors and increases authorized shares to 7.5B
-----------------------------------------------------------------------

- Elected directors: David Jeffs, George Adams, Joao (John) Da Costa, Amir Vahabzadeh effective April 1, 2024.
- Authorized common stock increased from 300M to 7.5B shares ($0.001 par value).
- Increase approved by written consent of stockholders holding 66% of outstanding shares.
- No other material corporate changes were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493712/000139390524000114/0001393905-24-000114-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493712/000139390524000114/cmxc-20240401.htm
  HTML page:      https://secwatch.observer/filing/0001393905-24-000114

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer